India’s National Pharmaceutical Pricing Authority has backed down from regulations allowing price caps on non-essential drugs, following the Delhi High Court’s request for drug makers to meet with the NPPA and resolve the disagreement. Several companies, however, have started withdrawing their products under price control and availability is going down. Read more here. (Source: Joe BarberFirstWord Pharma, 9/23/14).
You are here: / / India’s NPPA Withdraws Guidelines Allowing For Price Caps